
We are removing our rating from Specialty Laboratories SP after the company announced Monday that it has agreed to an all-cash buyout offer from privately held AmeriPath. Because
Specialty Laboratories SP announced on Monday that CEO Douglas Harrington would leave the company at the end of March. We believe this resignation announcement